| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparison of Survival by Site of Metastatic Resection in Metastatic Colorectal Cancer
|
Lee-Ying, Richard
|
|
2017
|
16 |
2 |
p. e23-e28
nvt p.
|
artikel
|
| 2 |
Acute Oxaliplatin-induced Hemolytic Anemia, Thrombocytopenia, and Renal Failure: Case Report and a Literature Review
|
Phull, Pooja
|
|
2017
|
16 |
2 |
p. e105-e107
nvt p.
|
artikel
|
| 3 |
Adherence, Dosing, and Managing Toxicities With Trifluridine/Tipiracil (TAS-102)
|
Lee, James J.
|
|
2017
|
16 |
2 |
p. 85-92
8 p.
|
artikel
|
| 4 |
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES)
|
Pinter, Tamás
|
|
2017
|
16 |
2 |
p. 103-114.e3
113898 p.
|
artikel
|
| 5 |
Capecitabine and Oxaliplatin Before, During, and After Radiotherapy for High-Risk Rectal Cancer
|
Larsen, Finn Ole
|
|
2017
|
16 |
2 |
p. e7-e14
nvt p.
|
artikel
|
| 6 |
Ectopic Gastric and Intestinal Phenotypes, Neuroendocrine Cell Differentiation, and SOX2 Expression Correlated With Early Tumor Progression in Colorectal Laterally Spreading Tumors
|
Katano, Takahito
|
|
2017
|
16 |
2 |
p. 141-146
6 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2017
|
16 |
2 |
p. A1-
1 p.
|
artikel
|
| 8 |
Efficacy and Safety of Bevacizumab Combined With Fluoropyrimidine Monotherapy for Unfit or Older Patients With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
|
Pinto, Carmine
|
|
2017
|
16 |
2 |
p. e61-e72
nvt p.
|
artikel
|
| 9 |
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study
|
Cheng, Ann-Lii
|
|
2017
|
16 |
2 |
p. e73-e88
nvt p.
|
artikel
|
| 10 |
Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis
|
Romiti, Adriana
|
|
2017
|
16 |
2 |
p. e55-e59
nvt p.
|
artikel
|
| 11 |
From Shelf to Bedside—Wearable Electronic Activity Monitoring Technologies Might Assist Oncologists in Functional Performance Status Assessment of Older Cancer Patients
|
Kelly, Ciara M.
|
|
2017
|
16 |
2 |
p. e115-e118
nvt p.
|
artikel
|
| 12 |
Gastrointestinal Perforation and Fistula Formation in 5 Patients With Colorectal Cancer During Treatment With Regorafenib
|
Doi, Ayako
|
|
2017
|
16 |
2 |
p. e109-e113
nvt p.
|
artikel
|
| 13 |
Gemcitabine-Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine
|
Turner, Jeffrey L.
|
|
2017
|
16 |
2 |
p. e119-e122
nvt p.
|
artikel
|
| 14 |
Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer
|
Zhang, Ben Y.
|
|
2017
|
16 |
2 |
p. 124-128
5 p.
|
artikel
|
| 15 |
mFOLFOX6 Plus Panitumumab Versus 5-FU/LV Plus Panitumumab After Six Cycles of Frontline mFOLFOX6 Plus Panitumumab: A Randomized Phase II Study of Patients With Unresectable or Advanced/Recurrent, RAS Wild-type Colorectal Carcinoma (SAPPHIRE)—Study Design and Rationale
|
Nagata, Naoki
|
|
2017
|
16 |
2 |
p. 154-157.e1
1417 p.
|
artikel
|
| 16 |
Observational Cohort Study of Patients With Metastatic Colorectal Cancer Initiating Chemotherapy in Combination With Bevacizumab (CONCERT)
|
Bennouna, Jaafar
|
|
2017
|
16 |
2 |
p. 129-140.e4
1.399872E6 p.
|
artikel
|
| 17 |
Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer
|
Rashtak, Shahrooz
|
|
2017
|
16 |
2 |
p. 115-123.e3
122886 p.
|
artikel
|
| 18 |
Peritoneal Carcinomatosis in Colorectal Cancers – Management Perspective Needs a Change
|
Bhandare, Manish
|
|
2017
|
16 |
2 |
p. e1-e6
nvt p.
|
artikel
|
| 19 |
Population-Based Patterns and Factors Associated With Underuse of Palliative Systemic Therapy in Elderly Patients With Metastatic Colon Cancer
|
Chan, Matthew
|
|
2017
|
16 |
2 |
p. 147-153
7 p.
|
artikel
|
| 20 |
Prophylactic Use of Oral Dexamethasone to Alleviate Fatigue During Regorafenib Treatment for Patients With Metastatic Colorectal Cancer
|
Fukuoka, Shota
|
|
2017
|
16 |
2 |
p. e39-e44
nvt p.
|
artikel
|
| 21 |
Quality of Life Analysis in Patients With RAS Wild-Type Metastatic Colorectal Cancer Treated With First-Line Cetuximab Plus Chemotherapy
|
Yamaguchi, Kensei
|
|
2017
|
16 |
2 |
p. e29-e37
nvt p.
|
artikel
|
| 22 |
Rationale for and Design of the PARADIGM Study: Randomized Phase III Study of mFOLFOX6 Plus Bevacizumab or Panitumumab in Chemotherapy-naïve Patients With RAS (KRAS/NRAS) Wild-type, Metastatic Colorectal Cancer
|
Yoshino, Takayuki
|
|
2017
|
16 |
2 |
p. 158-163
6 p.
|
artikel
|
| 23 |
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison
|
Masuishi, Toshiki
|
|
2017
|
16 |
2 |
p. e15-e22
nvt p.
|
artikel
|
| 24 |
Reviewing the Management of Obstructive Left Colon Cancer: Assessing the Feasibility of the One-stage Resection and Anastomosis After Intraoperative Colonic Irrigation
|
Awotar, Gavish Kumar
|
|
2017
|
16 |
2 |
p. e89-e103
nvt p.
|
artikel
|
| 25 |
Survival Impact of Adjuvant Chemotherapy for Resected Locally Advanced Rectal Adenocarcinoma
|
Tay, Rebecca Y.
|
|
2017
|
16 |
2 |
p. e45-e54
nvt p.
|
artikel
|
| 26 |
Table of Contents
|
|
|
2017
|
16 |
2 |
p. A2-A6
nvt p.
|
artikel
|
| 27 |
The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer
|
Wahab, S.M. Riajul
|
|
2017
|
16 |
2 |
p. 93-102
10 p.
|
artikel
|
Tijdschrift beschrijving